Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-02 Option Award |
2025-01-06 6:09 pm |
N/A 2035-01-02 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
11,714 | $0 | 11,714 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 8:14 pm |
N/A 2034-01-02 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
25,700 | $0 | 25,700 (Direct) |
View |
2023-01-16 Option Award |
2023-01-18 8:10 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
30,000 | $0 | 30,000 (Direct) |
View |
2022-05-26 Option Award |
2022-05-27 4:01 pm |
N/A 2032-05-26 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
20,000 | $0 | 20,000 (Direct) |
View |
2022-02-08 Conversion |
2022-02-09 5:54 pm |
N/A N/A |
Arcellx Inc. | ACLX | Williams Lewis T Director |
4,190,228 | $0 | 2,095,114 (Indirect) |
View |
Ownership |
2022-02-03 5:26 pm |
N/A N/A |
Arcellx Inc. | ACLX | Williams Lewis T Director |
0 | $0 | 2,095,114 (Indirect) |
View |
2021-05-27 Option Award |
2021-05-28 7:06 pm |
N/A 2031-05-26 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
18,000 | $0 | 18,000 (Direct) |
View |
2021-05-11 Option Award |
2021-05-13 5:39 pm |
N/A 2031-05-10 |
Neoleukin Therapeutics Inc. | NLTX | Williams Lewis T Director |
25,000 | $0 | 25,000 (Direct) |
View |
2020-05-28 Option Award |
2020-05-29 6:21 pm |
N/A 2030-05-27 |
Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director |
15,000 | $0 | 15,000 (Direct) |
View |
2020-05-05 Option Award |
2020-05-07 4:28 pm |
N/A 2030-05-05 |
Neoleukin Therapeutics Inc. | NLTX | Williams Lewis T Director |
25,000 | $0 | 25,000 (Direct) |
View |